Actively Recruiting
Genome Sequencing Evaluation for Newborns with Perinatal Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
Led by Baylor College of Medicine · Updated on 2026-10-01
25
Participants Needed
2
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying perinatal hypoxic-ischemic encephalopathy HIE, a serious condition affecting newborns due to lack of oxygen or blood flow before or during birth. The study aims to understand which newborns with HIE might have underlying genetic conditions by offering genome sequencing. This is important because recent evidence suggests genetics may play a role in many HIE cases, yet it is unclear which babies should receive genetic testing. Newborns diagnosed with moderate or severe HIE who are receiving therapeutic hypothermia total body cooling will undergo genome sequencing. This sequencing will analyze their genetic information and that of their parents to detect variations like copy number changes, single nucleotide variants, and repeat disorders according to established medical guidelines. The study focuses on newborns admitted to specific neonatal intensive care units. Participants will provide blood or buccal samples during their birth hospitalization for genome analysis. Researchers will measure the diagnostic yield of genome sequencing over 18 months, comparing genome versus exome sequencing results and noting any indeterminate findings. The study is conducted by Baylor College of Medicine and involves monitoring and evaluation throughout the neonatal period and beyond, with a total study completion expected in 2027.
CONDITIONS
Brief Title
The HIEnome Study: Genome Sequencing for Perinatal HIE
Research Team
C
Christian Parobek, MD, PhD
S
Seema Lalani, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here